2000 年和 2005 年，私人保险就业人群中 2 型糖尿病患者的直接医疗保健费用。
Direct health care costs of patients with type 2 diabetes within a privately insured employed population, 2000 and 2005.
机构信息
Healthcare & Science Department, Thomson Reuters, Washington, DC, USA.
出版信息
J Occup Environ Med. 2009 Dec;51(12):1460-5. doi: 10.1097/JOM.0b013e3181c2bb31.
OBJECTIVE
To assess the incremental economic burden of privately insured patients with type 2 diabetes (T2DM) in 2000 and 2005 in the United States.
METHODS
Adults with T2DM and 24 months of continuous health plan enrollment were identified in the MarketScan databases (2000 and 2005). Control groups of persons without diabetes were selected for comparison using propensity score matching. Total adjusted health care costs were estimated using generalized linear modeling.
RESULTS
Adjusted health care costs of patients with T2DM in 2005 were 136% higher than those of the matched controls ($12,733 vs $5406, P < 0.001). Similarly, costs of patients with T2DM in 2000 were 146% higher than those of the matched controls ($12,423 vs $5058, P < 0.001). Expenditures were similar for individuals with T2DM in 2000 and 2005.
CONCLUSIONS
T2DM continues to impose a substantial economic burden to self-insured employers.
目的
评估美国 2000 年和 2005 年私人保险患者 2 型糖尿病（T2DM）的增量经济负担。
方法
在 MarketScan 数据库中（2000 年和 2005 年）确定有 T2DM 和 24 个月连续健康计划参保的成年人。使用倾向评分匹配选择无糖尿病的人作为对照组进行比较。使用广义线性模型估计总调整后的医疗保健费用。
结果
2005 年 T2DM 患者的调整后医疗保健费用比匹配对照组高 136%（$12733 比$5406，P<0.001）。同样，2000 年 T2DM 患者的调整后医疗保健费用比匹配对照组高 146%（$12423 比$5058，P<0.001）。2000 年和 2005 年 T2DM 患者的支出相似。
结论
T2DM 继续给自付保险雇主带来巨大的经济负担。
Zotero 插件